Factors Affecting Infectious Endocarditis, Clinical Manifestation and Treatment Modalities – A Nurse's perspective and Overview
Life Sciences-Medicine
DOI:
https://doi.org/10.22376/ijlpr.2023.13.2.SP2.L27-L32Keywords:
Cardiac, Infective Endocarditis, Nurse,, Asepsis, HygieneAbstract
Infectious endocarditis virulent microorganisms colonize the endocardium heart valve. It is a rare disorder, and if it is not adequately recognized and treated, it can cause severe and quick morbidity and mortality; as per incidence in the US, approximately 10,000 to 15,000 are affected by infectious endocarditis. Nurses are critical in the prevention, early detection, early diagnosis workup, and prompt, successful care of this deadly disease and its complications. This article provides a review and updates on this striking yet ambiguous disease. Nurses will be effectively able to plan, incorporate, and evaluate the care required by this distinctive and demanding patient population if existing understanding is transferred into practice. Monitoring vitals like pulse, blood pressure, and temperature and alerting the physician significantly decreases morbidity. Administration of appropriate antibiotics at the proper doses and timing also matters. They also need to monitor the patient's renal status, including blood urea nitrogen levels, creatinine clearance levels, and urine output, especially a sudden appearance of blood in the urine. A Simple look at the nail beds for cyanosis is not a complete replacement for pulse oximetry but remains valid. As far as taking specimens for investigations, precise knowledge is needed. Using vacuum-extracted blood collection systems when we contemplate culture specimens is preferable. A complete education about possible infection sources and cleanliness, like decayed teeth, should be explained to patients. All plastics inside, like intravenous access and urinary catheter, should be treated with complete asepsis. As the disease is sudden, a calm, soothing approach towards patients and attendees goes a long way in getting better outcomes for these patients.
References
Geller SA. Infective endocarditis: a history of the development of its understanding. Autopsy Case Rep. (2013) 3:5–12. doi: 10.4322/acr.2013.033.
Mostaghim AS, Lo HYA. and Khardori N. A retrospective epidemiologic study to define risk factors, microbiology, and clinical outcomes of infective endocarditis in a sizeable tertiary-care teaching hospital. SAGE Open Med 2017;5:2050312117741772
Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, etiology, and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. (2019) 40:3222–32B. doi: 10.1093/eurheartj/ehz620.PubMed Abstract | CrossRef Full Text | Google Scholar.
Bayer AS, Bolger AF, Taubert KA. et al. Diagnosis and management of IE and its complications. AHA Scientific Statement. Circulation. 1998;98:2936–48
Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE, Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. European heart journal. 2007 Jan [PubMed PMID: 17158121].
Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH., International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009 Mar 09;169(5):463-73.
Manzano MC, et al. [Acute coronary syndrome in infective endocarditis] Rev Esp Cardiol. 2007;60:24–31.
Morel-Maroger L, Sraer JD, Herreman G, Godeau P. Kidney in subacute endocarditis. Pathological and immunofluorescence findings. Archives of pathology. 1972;94:205–213.
Murdoch DR, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Archives of internal medicine. 2009;169:463–473. This prospective cohort study of 2781 adults with definite endocarditis demonstrated that IE had shifted from a subacute disease of younger people with rheumatic valvular abnormalities to one in which the presentation is more acute and is characterized by a high rate of S. aureus infection in patients with previous health care exposure.
Miro JM, del Rio A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiology clinics. 2003;21:167–184. v–vi.
Kerr A, Jr, Tan JS. Biopsies of the Janeway lesion of infective endocarditis. Journal of cutaneous pathology. 1979;6:124–129
Jung J, et al. Incidence and Risk Factors of Ocular Infection Caused by Staphylococcus aureus Bacteremia. Antimicrobial agents and chemotherapy. 2016;60:2012–2017.
Topan A, Carstina D, Slavcovici A, Rancea R, Capalneanu R, Lupse M. Assessment of the Duke criteria for the diagnosis of infective endocarditis after twenty years. An analysis of 241 cases. Clujul Med. 2015;88(3):321-6. doi: 10.15386/cjmed-469. Epub 2015 Jul 1. PMID: 26609264; PMCID: PMC4632890.
Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer, et al., International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators., Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Archives of internal medicine. 2009 Mar 9 [PubMed PMID: 19273776].
Mohananey D, Mohadjer A, Pettersson G, et al. Association of vegetation size with embolic risk in patients with infective endocarditis: a systematic review and meta-analysis. JAMA Intern Med 2018;178:502.
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. (2000) 30:633–8. doi: 10.1086/313753.
Ribera E, Gómez-Jimenez J, Cortes E, Del Valle O, Planes A, Teresa Gonzalez-Alujas M, et al. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis: a randomized, controlled trial. Ann Intern Med. (1996) 125:969–74. doi: 10.7326/0003-4819-125-12-199612150-00005
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017 Jun 20; [PubMed PMID: 28298458].
WISNIEWSKI, AMY RN, BSN. Identifying infective endocarditis. Nursing: December 2003 - Volume 33 - Issue 12 - p 30.
Kashef MA, Friderici J, Hernandez-Montfort J, Atreya AR, Lindenauer P, Lagu T. Quality of Care of Hospitalized Infective Endocarditis Patients: Report from a Tertiary Medical Center. J Hosp Med. 2017 Jun;12(6):414-420. doi: 10.12788/jhm.2746
Published
How to Cite
Issue
Section
Copyright (c) 2023 Malarmathi . M, Raja lakshmi, Dhivya N, Meena .M

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

